Antimicrobial interventions for wounds

Microbiology of Wounds

Volumn , Issue , 2010, Pages 293-327

  Percival, Steven L ^a,b   Cooper, Rose A ^c   Lipsky, Benjamin A ^d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Advanced Medical Solutions   (United Kingdom)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751518680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420079944     Document Type: Chapter

References (211)

1. Forrest, R.D. (1982) Early history of wound healing. J Roy Soc Med 75:198-205.
2. Nelson, R. (2003) Antibiotic development pipeline runs dry-New drugs to fight resistant organisms are not being developed, experts say. Lancet 362:1726-1727.
3. McDonnel, G., and Russell, D. (1999) Antiseptics and disinfectants: Activity, action and resistance. Clin Microbiol Rev 12:147-179.
4. Harding, K.G. (1996). Managing wound infection. J Wound Care 8:391-392.
5. Gilchrist, B. (1997). Should iodine be reconsidered in wound management? J Wound Care 6:148-150.
6. Cooper, R.A. (2007). Iodine revisited. Int Wound J 4:124-137.
7. Gulliver, G. (1999) Wound care: Arguments over iodine. Nursing Times 95:68-70.
8. Bucknall, T.E. (1980) The effect of local infection upon wound healing: An experimental study. Br J Surg 67:851-855.
9. Robson, M.C., Stenberg, B.D., and Heggars, L. (1990) Wound healing alterations caused by infection. Clin Plast Surg 17(3):485-492.
10. Lyman, I.R., Tenery, J.H., and Basson, R.P. (1970) Correlation between decrease in bacterial load and rate of wound healing. Surg Gynecol Obstet 130(4):616-621.
11. Vowden, P., Apelqvist, J., and Moffat, C. (2008) Wound complexity and healing. In European Wound Management Association (EWMA) Position Document: Hard-to-heal wounds: A holistic approach. pp. 2-9. London. MEP.
12. Basu, S., Ramchuran Panray, T., Bali Singh, T., Gulati, A.K., and Shukla, V.K. (2009) A prospective, descriptive study to identify the microbiological profile of chronic wounds in outpatients. Ostomy Wound Manage 55(1):14-20.
13. Howell-Jones, R.S., Wilson, M.J., Hill, K.E., Howard, A.J., Price, P.E., and Thomas, D.W. (2005) A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 55(2):143-149.
14. Eron, L.J., Lipsky, B.A., Low, D.E., Nathwani, D., Tice, A.D., and Vilturo, G.A. (2003) Managing skin and soft tissue infections: Expert panel recommendations on key decision points. J Antimicrob Chemother 52(1):13-17.
15. Dinh, T.L., and Veves, A. (2006) Treatment of diabetic ulcers. Dermatol Ther 19(6):348-355.
16. Roghmann, M.C., Siddiqui, A., Plaisance, K., and Standiford, H. (2001) MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 47(2):98-103.
17. McGuckin, M., Goldman, R., Bolton, L., and Salcido, R. (2003) The clinical relevance of microbiology in acute and chronic wounds. Adv Skin Wound Care 16(1):12-23.
18. Dow, G., Browne, A., and Sibbald, R.G. (1999) Infection in chronic wounds:Controversies in diagnosis and treatment. Ostomy Wound Manage 45(8):23-7, 29-40.
19. White, R.J., Cutting, K., and Kingsley, A. (2006) Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage 52(8):26-58.
20. Chaby, G., Senet, P., Vaneau, M., Martel, P., Guillaume, J.C., Meaume, S., Téot, L., Debure, C., Dompmartin, A., Bachelet, H., Carsin, H., Matz, V., Richard, J.L., Rochet, J.M., Sales-Aussias, N., Zagnoli, A., Denis, C., Guillot, B., and Chosidow, O. (2007) Dressings for acute and chronic wounds: A systematic review. Arch Dermatol 143(10):1297-1304.
21. Thomas, S. (2006) Cost of managing chronic wounds in the UK, with particular emphasis on maggot debridement therapy. J Wound Care 15(10):465-469.
22. James, G.A., Swogger, E., Wolcott, R., Pulcini, E., Secor, P., Sestrich, J., Costerton, J.W., and Stewart P.S. (2008) Biofilms in chronic wounds. Wound Rep Regen 16(1):37-44.
23. Bjarnsholt, T., Kirketerp-Møller, K., Jensen, P.Ø., Madsen, K.G., Phipps, R., Krogfelt, K., Høiby, N., and Givskov, M. (2008) Why chronic wounds fail to heal: A new hypothesis. Wound Rep Regen 16(1):2-10.
24. Fux, C.A., Costerton, J.W., Stewart, P.S., and Stoodley, P. (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34-40.
25. Steed, D.L., Donohoe, D., Webster, M.W., and Lindsley, L. (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 183:61-64.
26. Steed, D.L. (2004) Debridement. Am J Surg 187:71S-74S.
27. Sibbald, R.G. et al. (2000) Preparing the wound bed-Debridement, bacterial balance, and moisture balance. Ostomy Wound Manage 46:14-18, 30.
28. Tarnuzzer, R.W., and Schultz, G.S. (1996) Biochemical analysis of acute and chronic wound environments. Wound Rep Regen. 4(3):321-325.
29. Rhoads, D.D., Wolcott, R.D., and Percival, S.L. (2008) Biofilms in wounds: Management strategies. J Wound Care 17(11):502-507.
30. Nemoto, K., Hirots, K., Murakami, K., Taniguti, K., Murata, H., Viducic, D., and Miyake, Y. (2003) Effect of varidase (streptodornase) on biofilm formed by Pseudomonas aeruginosa. Chemotherapy 49:121-125.
31. Johansen, C., Falholt, P., and Gram, L. (1997) Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol 63(9):3724-3728.
32. Baer, W.S. (1931) The treatment of chronic osteomyelitis with the maggot larvae of the blowfly. J Bone Joint Surg 13:438-475.
33. Chambers, L., Woodrow, S., Brown, A.P., Harris, P.D., Phillips, D., Hall, M., Church, J.C., and Pritchard, D.I. (2003) Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 148:14-23.
34. Van der Plas, Jukema, G.N., Wai, S.W., Dogterom-ballering, H.C., Lagendijk, E.L., van Gulpen, C., van Dissel, J.T., Bloemberg, G.Y., and Nibbering, P.H. (2008) Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 61:117-122.
35. Cazander, G., van Veen, K.E., Bouwman, L.H., Bernards, A.T., and Jukema, G.N. (2009) The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin Orthop Relat Res Feb;467(2):536-545.
36. Van der Plas, M.J., van der Does, A.M., Baldry, M., Dogterom-Ballering, H.C., van Gulpen, C., van Dissel, J.T., Nibbering, P.H., Jukema, G.N. (2007) Maggot excretions/secretions inhibit multiple neutrophil proinflammatory responses. Microbes Infect 9:507-514.
37. Dumville, J.C., Worthy, G., Bland, J.M., Cullum, N., Dowson, C., Iglesias, C., Mitchell, J.L., Nelson, E.A., Soares, M.O., Torgerson, D.J., and Venus II team. (2009) Larval therapy for leg ulcers (VenUS II): randomized controlled trial. BMJ 338:b773.
38. Lipsky, B.A. et al. (2004) Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885-910.
39. Anderl, J.N., Zahller, J., Roe, F., and Stewart, P.S. (2003) Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 47:1251-1256.
40. Walters, M.C., III, Roe, F., Bugnicourt, A., Franklin, M.J., and Stewart, P.S. (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47:317-323.
41. Brennan, S.S., and Leaper, D.J. (1985) The effect of antiseptics on the healing wound:A study using the rabbit ear chamber. Br J Surg 72(10):780-782.
42. Lineweaver, W., Howard, R., Soucy, D., McMorris, S., Freeman, J., Cairn, C., Roberston, J., and Rumley, T. (1985) Topical antimicrobial toxicity. Arch Surg 120:267-270.
43. Drosou, A., Falabella, A., and Kirsner, R.S. (2003) Antiseptics in wounds: A area of controversy. Wounds 15(5):149-166.
44. O’Meara, S.M., Cullum, N.A., Majid, M., and Sheldon, T.A. (2001) Systematic review of antimicrobial agents used for chronic wounds Br J Surg 88(1):4-21.
45. Gilchrist, B. (1997) Should iodine be reconsidered in wound management? J Wound Care 6:148-150.
46. Pierard-Franchimont, C., Paquet P., Arrese, J.E., and Pierard, G.E. (1997) Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology 194:383-387.
47. Lineaweaver, W., Soucy, D., and Howard, R. (1985). Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 75:394-396.
48. Mayer, D.A., and Tsapogas, M.J. (1993). Povidone-iodine and wound healing: A critical review. Wounds 5:14-23.
49. Eming, S.A., Smola-Hess, S., Kurschat, P., Hirche, D., Krieg, T., and Smola, H. (2006) A novel property of povidone-iodine: Inhibition of excessive protease levels in chronic non-healing wounds. J Invest Dermatol 126: 2731-2733.
50. Gruber, R.P., Vistnes, L., and Pardoe, R. (1975). The effect of commonly used antiseptics on wound healing. Plast Reconstr Surg 55:472-476.
51. Drosou, A., Falabella, A., and Kirsner, R.S. (2003). Antiseptics in wounds: An area of controversy. Wounds 15(5):149-166.
52. Mayer, D.A., and Tsapogas, M.J. (1993). Povidone-iodine and wound healing: A critical review. Wounds 5:14-23.
53. Durani, P., and Leaper, D. (2008) Povidone-iodine: Use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J 5:376-387.
54. Fleischer, W., and Reimer, K. (1997) Povidone-iodine in antisepsis: State of the art. Dermatology 195:3-9.
55. Leaper, D.J., and Durani, P. (2008) Topical antimicrobial therapy of chronic wounds healing by secondary intention using iodine products. Int Wound J 5:361-368.
56. Favero, M.S., and Drake, C.H. (1966) Factors influencing the occurrence of high numbers of iodine-resistant bacteria in iodinated swimming pools. Appl Microbiol 14(4):627-635.
57. Mycock, G. (1985) Methicillin/antiseptic-resistant Staphylococcus aureus. Lancet 2:949-950.
58. Harvey, S.C. (1985) Antiseptics and disinfectants. In Gilman, A.G., and Goodman L.S., et al. (Eds.) The Pharmacological Basis of Therapeutics (7th ed.). New York: Macmillan.
59. Schreier, H., Erdos, G., Reimer, K., König, B., König, W., and Fleischer, W. (1997) Dermatology 195(2):111-116.
60. Han, K.H., and Maitra, A.K. (1989) Management of partial skin thickness burn wounds with Inadine dressings. Burns 15:399-402.
61. Audanaska, H., and Gustavson, B. (1988) In patient treatment of chronic varicose venous ulcers; A randomised trial of cadexomer iodine versus standard dressings. J Int Med Res 16:428-435.
62. Moberg, S., Hoffman, L., Grennert, M.L., and Holst, A. (1983) A randomised trial of cadexomer iodine in decubitus ulcers. J Am Geriatr Soc 8:462-465.
63. Tomoyuki, O., Mizuashi, M., Ito, Y., and Aiba, S. (2007) Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages. Exp Dermatol 16:318-323.
64. Ivins, N., Simmonds, W., Turner, A., and Harding, K. (2007) The use of an oxygenating hydrogel dressing in VLU. Wounds UK 2007 3:1-5.
65. Maillard, J.-Y. (2002) Bacterial target for biocide action. J Applied Microbiol Symp Supp 92:16S-27S.
66. Pyle, B.H., and McFeters, G.A. (1990) Iodine susceptibility of pseudomonads grown attached to stainless steel surfaces. Biofouling 2:113-120.
67. Cargill, K.L., Pyle, B.H., Sauer, R.L., and McFeters G.A. (1992) Effects of culture conditions and biofilm formation on the iodine susceptibility of Legionella pnueumophila. Can J Microbiol 38:423-429.
68. Kunisada, T., Yamada, K., Oda, S., and Hara, O. (1997) Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 195:14-18.
69. Presterl, E., Suchomel, M., Eder, M., Reichmann, S., Lassnigg, A., Graninger, W., and Rotter, M. (2007) Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 60:417-420.
70. Akiyama, H., Oono, T., Saito, M., and Iwatsuki, K. (2004) Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol 31: 529-534.
71. Ivins, N., Simmonds, W., Turner, A., and Harding, K. (2007) The use of an oxygenating hydrogel dressing in VLU. Wounds UK 2007. 3:1-5.
72. Leaper, D.J. (2006) Silver dressings: Their role in wound management. Int Wound J 3(4):282-294.
73. Rai, M., Yadav, A., and Gade, A. (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76-83.
74. Percival, S.L., Bowler, P., and Russell, D. (2005) Bacterial resistance to silver and its impact to woundcare, J Hosp Infect 60:1-7.
75. Woods, E.J., Cochrane, C.A., and Percival, S.L. (2009) Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Vet Microbiol Mar 24.
76. Landsdown, A.B., and Williams, A. (2007) Bacterial resistance to silver in wound care and medical devices. J Wound Care 16(1):15-19.
77. Percival, S.L., Cochrane, C., Nutekor, M., and Silver, S. (2008) Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manage 54(3):30-40.
78. Woods, E.J., Cochrane, C.A., and Percival, S.L. (2009) Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Vet Microbiol 138:325-329.
79. Yin, H.Q., Langford, R., and Burrell, R. (1999) Comparative evaluation of the antimicrobial activity of Acticoat antimicrobial barrier dressing. J Burn Care Rehab 20:195-200.
80. Slawson, R.M., Lee, H., and Trevors, J.T. (1990) Bacterial interactions with silver. Biol Met 3(3-4):151-154.
81. Slawson, R.M., Van Dyke, M.I., Lee, H., and Trevors, J.T. (1992) Germanium and silver resistance, accumulation, and toxicity in microorganisms. Plasmid 27(1):72-79.
82. Thurman, R.B., and Gerba, C.O. (1989) The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. Crit Rev Environ Control 18:295-315.
83. Liau, S.Y., Read, D.C., Pugh, W.J., Furr, J.R., and Russell, A.D. (1997) Interaction of silver nitrate with readily identifiable groups: Relationship to the antibacterial action of silver ions. Lett Appl Microbiol 25(4):279-283.
84. Silvestry-Rodriguez, N., Bright, K.R., Uhlmann, D.R., Slack, D.C., and Gerba, C.P. (2007) Inactivation of Pseudomonas aeruginosa and Aeromonas hydrophila by silver in tap water. J Environ Sci Health A Tox Hazard Subst Environ Eng 42(11):1579-1584.
85. Silvestry-Rodriguez, N., Bright, K.R., Slack, D.C., Uhlmann, D.R., and Gerba, C.P. (2008) Silver as a residual disinfectant to prevent biofilm formation in water distribution systems. Appl Environ Microbiol 74(5):1639-1641.
86. Silvestry-Rodriguez, N., Sicairos-Ruelas, E.E., Gerba, C.P., and Bright, K.R. (2007) Silver as a disinfectant. Rev Environ Contam Toxicol 191:23-45.
87. De Prijck, K., Nelis, H., and Coenye, T. (2007) Efficacy of silver-releasing rubber for the prevention of Pseudomonas aeruginosa biofilm formation in water. Biofouling 23(5-6):405-411.
88. Gentry, H., and Cope, S. (2005) Using silver to reduce catheter-associated urinary tract infections. Nurs Stand 19:51-54.
89. Ionescu, A., Payne, N., Fraser, A.G., Giddings, J., Grunkemeier, G.L., and Butchart, E.G. (2003) Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: Experience from the Cardiff Embolic Risk Factor Study. Heart Sep;89(9):1055-1061.
90. Darouiche, R.O. (1999) Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 29(6):1371-1377.
91. Wu, M.Y., Suryanarayanan, K., van Ooij, W.J., and Oerther, D.B. (2007) Using microbial genomics to evaluate the effectiveness of silver to prevent biofilm formation. Water Sci Technol 55(8-9):413-419.
92. Bjarnsholt, T., Kirketerp-Møller, K., Kristiansen, S., Phipps, R., Nielsen, A.K., Jensen, P.Ø., Høiby, N., and Givskov, M. (2007) Silver against Pseudomonas aeruginosa biofilms. APMIS 115(8):921-928.
93. Chaw, K.C., Manimaran, M., and Tay, F.E. (2005) Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofolms. Antimicrob Agents Chemother 49(12):4853-4859.
94. Percival, S.L., Bowler, P., and Woods, E.J. (2008) Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 16(1):52-57.
95. Valappil, S.P., Knowles, J.C., and Wilson, M. (2008) Effect of silver-doped phosphatebased glasses on bacterial biofilm growth. Appl Environ Microbiol 74(16):5228-5230.
96. Kim, J., Pitts, B., Stewart, P.S., Camper, A., and Yoon, J. (2008) Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm. Antimicrob Agents Chemother 52(4):1446-1453.
97. Fabry, W., Trampenau, C., Bettag, C., Handschin, A.E., Lettgen, B., Huber, F.X., Hillmeier, J., and Kock, H.J. (2006) Bacterial decontamination of surgical wounds treated with Lavasept. Int J Hyg Environ Health 209(6):567-573.
98. Santodomingo-Rubido, J. (2007) The comparative clinical performance of a new polyhexamethylene biguanide- versus a polyquad-based contact lens care regime with two silicone hydrogel contact lenses. Ophthalmic Physiol Opt 27(2):168-173.
99. Larkin, D.F.P., Kilvington, S., and Dart, J.K.G. (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185-191.
100. Lim, N., Goh, D., Bunce, C., Xing, W., Fraenkel, G., Poole, T.R., and Ficker, L. (2008) Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol 145(1):130-135.
101. Nascimento, A.P., Tanomaru, J.M., Matoba-Júnior, F., Watanabe, E., Tanomaru-Filho, M., and Ito, I.Y. (2008) Maximum inhibitory dilution of mouthwashes containing chlorhexidine and polyhexamethylene biguanide against salivary Staphylococcus aureus. J Appl Oral Sci 16(5):336-339.
102. Minozzi, M., Gerli, S., Di Renzo, G.C., Papaleo, E., and Ferrari, A. (2008) The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis. Eur Rev Med Pharmacol Sci 12(1):59-65.
103. Marelli, G., Papaleo, E., Origoni, M., Caputo, L., and Ferrari A. (2005) Polyhexamethylene biguanide for treatment of external genital warts: A prospective, double-blind, randomized study. Eur Rev Med Pharmacol Sci. 9(6):369-372.
104. Motta, G.J., Milne, C.T., and Corbett, L.Q. (2004) Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Manage 50(8):48-62.
105. Salas Campos, L., Gómez Ferrero, O., Estudillo Pérez, V., and Fernández Mansilla, M. (2006) Preventing nosocomial infections. Dressings soaked in polyhexamethylene biguanide (PHMB). Rev Enferm 29(6):43-48.
106. Nascimento, A.P., Tanomaru, J.M., Matoba-Júnior, F., Watanabe, E., Tanomaru-Filho, M., and Ito, I.Y. (2008) Maximum inhibitory dilution of mouthwashes containing chlorhexidine and polyhexamethylene biguanide against salivary Staphylococcus aureus. J Appl Oral Sci 16(5):336-339.
107. Vowden, K., and Vowden, P. (2003) Understanding exudate management and the role of exudate in the healing process. Br J Community Nurs 8(11 Suppl):4-13.
108. Broxton, P., Woodcock, P.M., and Gilbert, P. (1983) A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739. J Appl Bact, 5445-5453.
109. Allen, M.J., White, G.F., and Morby, A.P. (2006) The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 152(4):989-1000.
110. Ueda, S., and Kuwabara, Y. (2007) Susceptibility of biofilm Escherichia coli, Salmonella enteritidis and Staphylococcus aureus to detergents and sanitizers. Biocontrol Sci 12(4):149-153.
111. Russell, A.D. (2002) Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 92: 121S-135S.
112. Webster, J., and Osborne, S. (2007) Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2: CD004985
113. Tanner, J., Swarbrook, S., and Stuart, J. (2008) Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 1: CD004288
114. Lambert, P.M., Moris, H.F., and Ochi, S. (1997) The influence of 0.12% chlorhexidine gluconate rinses on the incidence of infectious complications and implant success. J Oral Maxillofac Surg 55:25-30.
115. Payne, D.N., Babb, J.R., and Bradley, C.R. (1999) An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms. Lett Appl Microbiol 28(1):7-12.
116. Cookson, B.D., Bolton, M.C., and Platt, J.H. (1991) Chlorhexidine resistance in methicillin- resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 35(10):1997-2002.
117. Millward, T.A., and Wilson, M. (1989) The effect of chlorhexidine on Streptococcus sanguis biofilms. Microbios 58:155-164.
118. Pratten, J., Barnett, P., and Wilson, M. (1998) Composition and susceptibility to chlorhexidine of multi-species biofilms of oral bacteria. Appl Environ Microbiol 64:3515-3519.
119. Sena, N.T., Gomes, B.P., Vianna, M.E., Berber, V.B., Zaia, A.A., Ferraz, C.C., and Souza-Filho, F.J. (2006) In vitro antimicrobial activity of sodium hypochlorite and chlorhexidine against selected single-species biofilms. Int Endod J 39(11):878-885.
120. Vitkov, L., Hermann, A., Krautgartner, W.D., Herrmann, M., Fuchs, K., Klappacher, M., and Hannig, M. (2005) Chlorhexidine-induced ultrastructural alterations in oral biofilm. Microsc Res Tech 68(2):85-89.
121. Taylor, K. (1916) Tissue Fragments and wound infection. Ann Surg 64(6):641-644.
122. Phillips, A.W. (1968) Burn therapy: V. Disaster management-to treat or not to treat? Who should receive intravenous fluids? Ann Surg 168(6):986-996.
123. Milner, S.M. (1992) Acetic acid to treat Pseudomonas aeruginosa in superficial wounds and burns. Lancet 340(8810):61.
124. Sloss, J.M., Cumberland, N., and Milner, S.M. (1993) Acetic acid used for the elimination of Pseudomonas aeruginosa from burn and soft tissue wounds. J R Army Med Corps 139(2):49-51.
125. Cooper, M.L., Laxer, J.A., and Hansbrough, J.F. (1991) The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 31(6):775-784.
126. Peeters, E., Nelis, H.J., and Coenye, T. (2008) Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms. J Hosp Infect 70(4):361-368.
127. Akiyama, H., Yamasaki, O., Tada, J., and Arata, J. (1999) Effects of acetic acid on biofilms formed by Staphylococcus aureus. Arch Dermatol Res 291(10):570-573.
128. Oh, D.H., and Marshall, D.L. (1996) Monolaurin and acetic acid inactivation of Listeria monocytogenes attached to stainless steel. J Food Prot 59(3):249-252.
129. Crane, E. (1999). The World History of Beekeeping and Honey Hunting. London:Duckworth.
130. Cooper, R.A., and Jenkins, L. (2009) A comparison between medical grade honey and table honeys in relation to antimicrobial efficacy. Wounds 21(2):29-36.
131. Molan, P.C., and Hill, C. (2009) Quality standards for medical grade honey. In: Cooper RA, Molan, P.C. White, R. (Eds.) Honey in Modern Wound Management. HealthComm, United Kingdom.
132. Molan, P.C. (2006). The evidence supporting the use of honey as a wound dressing. Int J Lower Extremity Wounds 5:40-54.
133. Gethin, G., and Cowman, S. (2009) Manuka honey vs. hydrogel: A prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs 18(3):466-474.
134. Jull, A., Walker, N., Parag, V., Molan, P., and Rodgers, A. (2008) Honey as adjuvant leg ulcer therapy trial collaborators. Randomised clinical trial of honey-imprgenated dressings for venous leg ulcers. Br J Surg 95(2):175-182.
135. Robson, V., Dodd, S., and Thomas, S. (2009) Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs 65(3):565-575.
136. Moore, O.A., Smith, L.A., Campbell, F., Seers, K., McQuay, H.J., and Moore, R.A. (2001) Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 1:2.
137. Jull, A.B., Rodgers, A., and Walker, N. (2008) Honey as a topical treatment for wounds. Cochrane Database Syst Rev (4):CD005083.
138. Brady, J., Slevin, N.J., Mais, K.L., and Molassiotis, A. (2008) A systematic review of honeybuses and its potential value within oncology. J Clin Nurs 17:2604-2623.
139. Molan, P.C. (1992) The antibacterial nature of honey: 1. The nature of the antibacterial activity. Bee World 73(1):5-28.
140. Bang, L.M., Buntting, C., and Molan, P.C. (2003) The effects of dilution rate on hydrogen peroxide production in honey and its implications for wound healing. J Altern Compl Med 9(21):267-273.
141. Mavric, E., Wittmann, S., Barth, G., and Henle, T. (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Foods Res 52:483-489.
142. Adams, C.J., Boult, C.H., Deadman, B.J., Farr, J.M., Grainger, M.N.C., Manley-Harris, M., and Snow, M.J. (2008) Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343:651-659.
143. Blair, S.E., and Carter, D.A. (2005). The potential for honey in the management of wounds and infections. J Aust Infect Control 10(1):24-31.
144. Irish, J. et al. (2006) Honey has an antifungal effect against Candida species. Med Mycol 44:289-291.
145. Brady, N.F., Molan, P.C., and Harfoot, C.G. (1996). The sensitivity of dermatophytes to the antimicrobial activity of manuka honey and other honey. Pharm Sci 2:1-3.
146. Zeina, B., Zohra, B.I., and Al-Assad, S. (1997). The effects of honey on Leishmania parasites: An in vitro study. Tropical Doctor suppl 1:36-38.
147. Al-Waili, N.S. (2004). Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions. Med Sci Monit 10(8): 94-98.
148. Cooper, R.A., Molan, P.C., and Harding, K.G. (2002) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93(5):857-863.
149. Cooper, R.A., Halas, E., and Molan, P.C. (2002) The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J. Burns Care Rehab 23(6):366-370.
150. Okhiria, O.A., Henriques, A.F.M., Burton, N.F., Peters, A., and Cooper, R.A. (2009) Honey modulates biofilms of Pseudomonas aeruginosa in a time and dose dependent manner. J. ApiProduct ApiMedical Science 1(1):6-10.
151. Alandejani, T., Marsan, J.G., Ferris, W., and Chan, F. (2008) Effectiveness of honey on S. aureus and P. aeruginosa biofilms. Otolaryngol Head Neck Surg 139(1):107.
152. Lerrer, B., Zinger-Yosovich, K.D., Avrahami, B., and Gilboa-Garber, N. (2007) Honey and royal jelly, like human milk, abrogate lectin-dependent infection-preceding Pseudomonas aeruginosa adhesion. ISME J, 1(2):149-155.
153. Alnaqdy, A., Al-Jabri, A., Al Mahrooqi, Z., Nzeako, B., and Nsanze, H. (2005) Inhibition effect of honey on the adherence of Salmonella to intestinal epithelial cells in vitro. Int J Food Microbiol 103:347-351.
154. Sauer, K., Cullen, M.C.C., Rickard, A.H., Zeef, A.H., Davies, D.G., and Gilbert, P. (2004) Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bact 186(21):7312-7326.
155. English, H.K.P., Pack, A.R.C., and Molan, PC. (2004) The effects of manuka honey on plaque and gingivitis: A pilot study. J Int Acad Periodontol 6:63-67.
156. Rodeheaver, G.T. (1997) Wound cleansing, wound irrigation, wound disinfection. In Krasner, D., and Kane, D. (Eds.), Chronic Wound Care: A Clinical Source Book for Healthcare Professionals (2nd ed.), Wayne, PA: Health Management Publications, pp. 97-108.
157. Campos-Martin, J.M., Blanco-Brieva, G., and Fierro J.L.G. (2006) Hydrogen peroxide synthesis: An outlook beyond the anthraquinone process. Angewandte Chemie Int Ed 45(42):6962-6984.
158. Sleigh, J.W., and Linter, S.P. (1985) Hazards of hydrogen peroxide. Br Med J (Clin Res Ed) 291(6510):1706.
159. DeQueiroz, G.A., and Day, D.F. (2007) Antimicrobial activity and effectiveness of a combination of sodium hypochlorite and hydrogen peroxide in killing and removing Pseudomonas aeruginosa biofilms from surfaces. J Appl Microbiol 103(4):794-802.
160. Baldeck, J.D., and Marquis, R.E. (2008) Targets for hydrogen-peroxide-induced damage to suspension and biofilm cells of Streptococcus mutans. Can J Microbiol Oct; 54(10):868-875.
161. Glynn, A.A., O’Donnell, S.T., Molony, D.C., Sheehan, E., McCormack, D.J., and O’Gara, J.P. (2009) Hydrogen peroxide induced repression of icaADBC transcription and biofilm development in Staphylococcus epidermidis. J Orthop Res 27(5):627-630.
162. Surdeau, N., Laurent-Maquin, D., Bouthors, S., and Gellé, M.P. (2006) Sensitivity of bacterial biofilms and planktonic cells to a new antimicrobial agent, Oxsil 320N. J Hosp Infect 62(4):487-493.
163. Bullen, J.J. (1975) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad Med J 51(3):67-70.
164. Oseas, R., Yang, H.H., Baehner, R.L., and Boxer, L.A. (1981) Lactoferrin: A promoter of polymorphonuclear leukocyte adhesiveness. Blood 57:939-945.
165. Brandenburg, K., Jurgens, G., Muller, M., Fukuoka, S., and Koch, M.H. (2001) Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 382:1215-1225.
166. Appelmelk, B. J. et al. (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628-2632.
167. Ellison, R.T., III, Giehl, T.J., and LaForce, F.M. (1988) Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774-2781.
168. Ochoa, T.J. et al. (2003) Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun 71:5149-5155.
169. Singh, P.K., Parsek, M.R., Greenberg, E.P., and Welsh, M.J. (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555.
170. Weinberg, E.D. (2004) Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63(5):863-865.
171. Ammons, M.C.B., Ward, L.S., Fisher, S.T., Wolcott, R.D., and James, G.A. (2008) In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents.
172. Granstrom, T.B., Izumori, K., and Leisola, M. (2007) A rare sugar xylitol. Part II:Biotechnological production and future applications of xylitol. Appl Microbiol Biotechnol 74:273-276.
173. Uhari, M., Tapiainen, T., and Kontiokari, T. (2000) Xylitol in preventing acute otitis media. Vaccine 19(1):S144-S147.
174. Tapiainen, T. et al. (2004) Ultrastructure of Streptococcus pneumoniae after exposure to xylitol. J Antimicrob Chemother 54:225-228.
175. Katsuyama, M., Ichikawa, H., Ogawa, S., and Ikezawa, Z. (2005) A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 38:197-205.
176. Ammons, M.C., Ward, L.S., Fisher, S.T., Wolcott, R.D., and James, G.A. (2009) In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 33(3):230-236.
177. Kutter, E., and Sulakvelidze, A. (2005) Bacteriophages: Biology and Applications. Boca Raton, FL: CRC Press.
178. Parisien, A., Allain, B., Zhang, J., Mandeville, R., and Lan, C.Q. (2008) Novel alternatives to antibiotics: Bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol 104(1):1-13.
179. Capparelli, R., Parlato, M., Borriello, G., Salvatore, P., and Iannelli, D. (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51(8):2765-2773.
180. McVay, C.S., Velásquez, M., and Fralick, J.A. (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51(6):1934-1938.
181. Adams, M.H., and Park, B.H. (1956) An enzyme produced by a phage-host cell system. II. The properties of the polysaccharide depolymerase. Virology 2:719-736.
182. Donlan, R.M. (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17(2):66-72.
183. Doolittle, M.M., Cooney, J.J., and Caldwell, D.E. (1995) Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can J Microbiol 41:12-18.
184. Hughes, K.A., Sutherland, I.W., Clark, J., and Jones, M.V. (1998) Bacteriophage and associated polysaccharide depolymerases-Novel tools for study of bacterial biofilms. J Appl Microbiol 85:583-590.
185. Hughes, K.A., Sutherland, I.W., and Jones, M.V. (1998) Biofilm susceptibility to bacteriophage attack: The role of phage-borne polysaccharide depolymerase. Microbiology 144(11):3039-3047.
186. Sutherland, I.W., Hughes, K.A., Skillman, L.C., and Tait, K. (2004) The interaction of phage and biofilms. FEMS Microbiol Lett 232(1):1-6.
187. Kite, P., Eastwood, K., Sugden, S., and Percival, S.L. (2004) Use of in-vivo generated biofilms from haemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in-vitro. J Clin Microbiol 42:3073-3076.
188. Percival, S.L., Kite, P., and Donlan, R. (2005) Assessing the effectiveness of tetrasodium ethylenediaminetetraacetic acid as a novel central venous catheter (CVC) lock solution against biofilms using a laboratory model system. Infect Control Hosp Epidemiol 26(6):515-519.
189. Eastwood, K., Kite, P., and Percival, S.L. (2005) The effectiveness of TEDTA on biofilm eradication. Biofilm Club, Biofilm Club September 6-8, Bioline, Gregynog, Cardiff.
190. Brown, M.R., and Richards, R.M. (1965). Effect of ethylenediamine tetraacetate on the resistance of Pseudomonas aeruginosa to antibacterial agents. Nature 207:1391-1393.
191. Gray, G.W., and Wilkinson, S.G. (1965). The effect of ethylenediaminetetraacetic acid on the cell walls of some Gram-negative bacteria. J Gen Microbiol 39:385-399.
192. Leive, L. (1965). Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun 21:290-296.
193. Raad, I.I., Fang, X., Keutgen, X.M., Jiang, Y., Sherertz, R., and Hachem, R. (2008) The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21(4):385-392.
194. Percival, S.L., Kite., P., and Stickler, D. (2009) The use of urinary catheters and control of biofilms using TEDTA. Urological Research 37:205-209.
195. Root, J.L., McIntyre, R.O., Jacobs, N.J., and Daghlian, C.P. (1988). Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: Relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 32:1627-1631.
196. Raad, I., Chatzinikolaou, I., Chaiban, G., Hanna, H., Hachem, R., Dvorak, T., Cook, G., and Costerton, W. (2003). In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47:3580-3585.
197. Raad, I., Hanna, H., Dvorak, T., Chaiban, G., and Hachem, R. (2007). Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51:78-83.
198. Raad, I., Hachem, R., Tcholakian, R.K., and Sherertz, R. (2002). Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46:327-332.
199. Kim, H.-J., Dorn, V.L., and VanBriesen, J.M. (2004). The efficacy of ethylenediaminetetraacetic acid (EDTA) against biofilm bacteria. Biomedical Engineering Society Annual Meeting, Fall 2004.
200. Banin, E., Brady, K.M., and Greenberg, E.P. (2006). Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72:2064-2069.
201. Ramage, G., Wickes, B.L., and López-Ribot, J.L. (2007). Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164:301-306.
202. Kite, P., Eastwood, K., Sugden, S., and Percival, S.L. (2004) Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42:3073-3076.
203. Percival, S.L., Kite, P., Eastwood, K., Murga, R., Carr, J., Arduino, M.J., and Donlan, R.M. (2005). Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 25:515-519.
204. Devine, D.A., Percival, R.S., Wood, D.J., Tuthill, T.J., Kite, P., Killington, R.A., and Marsh, P.D. (2007). Inhibition of biofilms associated with dentures and toothbrushes by tetrasodium EDTA. J Appl Microbiol 103:2516-2424.
205. Martineau, L., and Dosch, H.-M. (2007). Biofilm reduction by a new burn gel that targets nociception. J Appl Microbiol 103:297-304.
206. Martineau, L., and Dosch, H.-M. (2007). Management of bioburden with a burn gel that targets nociceptors. J Wound Care 16:157-164.
207. Brady, A., Loughlin, R., Gilpin, D., Kearney, P., and Tunney, M. (2006) In vitro activity of tea-tree oil against clinical isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 41(1):52-55.
208. Dalleau, S., Cateau, E., Berges, T., Berjeaud, J-M., and Imbert, C. (2008) In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents 31:572-576.
209. Tanner, J., Swarbrook, S., and Stuart, J. (2008) Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst. Rev. (1):CD004288.
210. Webster, J., and Osborne, S. (2007) Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst. Rev. (2):CD004985.
211. Vermeulen, H., van Hattem, J.M., Storm-Versloot, M.N., and Ubbink, D.T. (2007) Topical silver for treating infected wounds. Cochrane Database Syst Rev. (1):CD005486.